US 7572920
Benzimidazole derivative and use as a II receptor antagonist
granted A61PA61P13/12A61P25/00
Quick answer
US patent 7572920 (Benzimidazole derivative and use as a II receptor antagonist) held by Takeda Pharmaceutical Company Limited expires Mon Aug 06 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Aug 11 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 06 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61P, A61P13/12, A61P25/00, A61P25/28, A61P3/00